Emergent BioSolutions lands 20M for chemical weapon antidote Washington Business Journal

The product would reverse the effects of chemicals that disrupt nerve function for military and other emergency situations.

Image: Bob Kramer is president and CEO of Emergent BioSolutions. COURTESY EMERGENT BIOSOLUTIONS